Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …

The in vitro susceptibility testing interpretive criteria (STIC) for piperacillin/tazobactam (TZP)
against Enterobacterales were recently updated by the US Food and Drug Administration …

Abstract Introduction The ESCPM group (Enterobacter species including Klebsiella
aerogenes-formerly Enterobacter aerogenes, Serratia species, Citrobacter freundii complex …

Background Ventilator associated pneumonia (VAP) due to wild-type AmpC-producing
Enterobacterales (wtAE) is frequent in intensive care unit (ICU) patients. Despite a low level …

AmpC β-lactamases are associated with development of ceftriaxone resistance despite
initial in vitro susceptibility, but the risk of AmpC derepression is not equal among …

For critically ill patients with bloodstream infections caused by MDRGNB, the use of newly
developed antibiotics is recommended based on limited observational evidence. Further …

Purpose Indicators for comparing and understanding differences in antimicrobial resistance
(AMR) and healthcare-associated infections (HAIs) for benchmarking are essential to …

Rapid microbiological diagnosis of the antibiotic susceptibility of Gram-negative bacilli is a
priority in clinical microbiology, especially in cases of bacteremia. The rapid advancement of …

AmpC enzymes are a class of beta-lactamases produced by Gram-negative bacteria,
including several Enterobacterales. When produced in sufficient amounts, AmpCs can …

Background The best treatment for bloodstream infections (BSI) due to chromosomal AmpC
(c-AmpC) producing Enterobacterales is not clearly defined. Objectives To describe the …